According to the research team, with the mathematical process created in Gijon, the cost of discriminatory testing may be reduced from 3,000 to 200 euros.
The development of this mathematical model that predicts which patients are going to suffer from the spread of cancer, may lead to significant savings in the cost of treating this type of tumour. The system, based on finding a protein, has been developed by the team of researchers at the Jove Hospital Foundation in Gijon.
The Research Unit team argues that this line of action will be cheaper and more reliable than methods used today to predict metastasis. Although it is hoped more tests will be performed upon more patients from the Clínica Universidad de Navarre, after analysing the results of the tests carried out on 200 people, all the artificial intelligence-based project needs now is economic support in the form of investment for commercialisation.
Another important line of research undertaken at the Jove Hospital Unit, and which will have optimum use in cancers that are difficult to operate upon, is the project based on the micro-algae spirulina, with which tumours may be eliminated from cells damaged by the illness.
These innovative actions from the Jove Hospital in Gijon, including the considerable progress made in the uterine stem cells that will have both curative and regenerative uses, as well as many other lines of research and patents developed by Asturian science teams, are a clear demonstration that research in such fundamental issues such as health carry a lot of weight in Asturias.
The Jove Hospital Foundation: a source of research
The Jove Hospital has had a Research Unit for over 20 years. Here, numerous projects and lines of investigation are carried out, leading to important medical advances.
Over these two decades of work, the Jove Hospital Foundation team has released scientific publications and its research projects have been acknowledged with various science awards.
